医学
生理学
泌尿生殖系统
微生物群
脆乳杆菌
内科学
雌激素
失调
激素疗法
激素
更年期
更年期
唾液
月经周期
妇科
肠道菌群
泌尿系统
内分泌学
细菌性阴道病
激素疗法
普雷沃菌属
强力霉素
雌酮
激素替代疗法(女性对男性)
乳酸菌
生物信息学
雄激素
流行病学
睾酮(贴片)
作者
Chen Chen,Lilan Hao,Wei Xie,Ruiyi Tang,Ruochun Guo,Zhibo Zhang,Jie Li,Liang Xiao,Xin Jin,Zheng Zheng,Chunxia Yin,Zhumei Sheng,Xiaoyin Hu,Shaoqiao Zhang,Chunlin Xu,Zhe Zhang,Qiulong Yan,Liang Xiao,Zheng Zheng,Chunxia Yin
标识
DOI:10.1038/s41591-026-04737-4
摘要
Menopausal hormone therapy (MHT) alleviates climacteric symptoms, yet its microbiome-wide effects and efficacy determinants remain unclear. Here we show that oral estradiol/dydrogesterone, given for 6 months to 356 perimenopausal women, improved neuroendocrine, metabolic and symptom outcomes and induced site-specific microbial remodeling. Vaginocervical and urinary niches showed the most pronounced restructuring, with moderate oral and minimal gut changes. MHT increased vaginocervical Lactobacillus crispatus and reduced Gardnerella vaginalis. Higher baseline vaginocervical L. crispatus predicted greater postintervention vaginocervical and urinary colonization and superior Female Sexual Function Index improvement. Baseline vaginocervical community types determined differential outcomes: G. vaginalis-dominated individuals shifted most toward healthier communities, whereas diversified individuals improved least. MHT efficacy also varied according to baseline gut community type: Phocaeicola vulgatus-dominated women exhibited greater hormonal responsiveness, superior clinical outcomes and were more likely to achieve 4-week rapid clinical remission than Prevotella copri-dominated women. These findings support a precision MHT framework integrating gut and vaginocervical community typing for personalized care. Chictr.org.cn ID: ChiCTR2100049768 .
科研通智能强力驱动
Strongly Powered by AbleSci AI